SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?


To: wlheatmoon who wrote (1132)2/26/1998 6:24:00 PM
From: invest04  Read Replies (1) | Respond to of 5736
 
In scanning Avalon's home page (where Ms. Reese works), it says:

"Avalon's research methodology, is a grass-roots approach, both unorthodox and unparalleled, which has proven to be highly effective. The process includes conversations and visits with corporate management and exhaustive checks with competitors, vendors, wholesalers and distributors. In addition, Avalon uses a vast information network of outside consultants, including highly experienced industry professionals."

And they never contacted CCSI management?

Also:

"Avalon Research has the ability to accumulate or distribute large blocks of stock anonymously. As 1 of more than 1,000 Bear Stearns correspondents and by using a highly experienced network of independent execution firms and market makers, your order is never "shopped" and your intentions are never public!"

Interesting...



To: wlheatmoon who wrote (1132)2/26/1998 7:54:00 PM
From: baggo  Read Replies (2) | Respond to of 5736
 
Mike,
Nothing like a podiatrist/investment research expert lighting up this board!! I'm not going to knock podiatrists;I work with some; contribute to my income. It's looks like,though, they can be just as misinformed as some of the other posters on this thread.
A non-invasive bilirubin test has an absolutely huge market. A non-invasive test for ANEMIA is 100x ,at least, larger.
Good luck all; perhaps one more buying opportunity.
Brice Guckien